Literature DB >> 6423040

Transient retinal ischaemia induced by nifedipine.

S Pitlik, R S Manor, I Lipshitz, G Perry, J Rosenfeld.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6423040      PMCID: PMC1550009          DOI: 10.1136/bmj.287.6408.1845-a

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  5 in total

1.  Pathogenesis of occlusion of the central retinal vessels.

Authors:  S S Hayreh
Journal:  Am J Ophthalmol       Date:  1971-11       Impact factor: 5.258

2.  Nifedipine and Prinzmetal's angina.

Authors:  S Keidar; A Marmor; E Grenadier; A Palant
Journal:  Circulation       Date:  1979-01       Impact factor: 29.690

3.  Erythematous oedema of the legs due to nifedipine.

Authors:  J F Bridgman
Journal:  Br Med J       Date:  1978-03-04

4.  Hemodynamic effects of a single oral dose of nifedipine following acute myocardial infarction.

Authors:  J C Debaisieux; P Theroux; D D Waters; H F Mizgala
Journal:  Chest       Date:  1980-10       Impact factor: 9.410

5.  Pulmonary oedema precipitated by nifedipine.

Authors:  D J Gillmer; P Kark
Journal:  Br Med J       Date:  1980-06-14
  5 in total
  6 in total

Review 1.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

2.  Once daily amlodipine in the treatment of mild to moderate hypertension.

Authors:  J Webster; O J Robb; T A Jeffers; A K Scott; J C Petrie; H M Towler
Journal:  Br J Clin Pharmacol       Date:  1987-12       Impact factor: 4.335

Review 3.  A comparative review of the adverse effects of calcium antagonists.

Authors:  H T Dougall; J McLay
Journal:  Drug Saf       Date:  1996-08       Impact factor: 5.606

Review 4.  Sustained release nifedipine formulations. An appraisal of their current uses and prospective roles in the treatment of hypertension, ischaemic heart disease and peripheral vascular disorders.

Authors:  D Murdoch; R N Brogden
Journal:  Drugs       Date:  1991-05       Impact factor: 9.546

5.  Slow release nifedipine and atenolol as initial treatment in blacks with malignant hypertension.

Authors:  C G Isles; A O Johnson; F J Milne
Journal:  Br J Clin Pharmacol       Date:  1986-04       Impact factor: 4.335

6.  Hypertensive urgency.

Authors:  Joel Handler
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-01       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.